C-NGEN

V:NGEN - Nervgen Pharma Corp. - http://www.nervgen.com/

10:07:18 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NGEN - V	1.0	2.24	·	2.28	0.6	2.24	+0.08	3.7	24.7	53	64	2.22 2.29 2.18	3.98 1.55	09:42:54	May 02	15 min RT 2¢
TSX-V - V	1.0	2.24	·	2.28	0.6	2.24	+0.08	3.7	20.7	45	47	2.22 2.29 2.18	3.98 1.55	09:42:54		15 min
NEO ATS - U						2.29	+0.13	6.0	1.0	2	7	2.22 2.29 2.22		09:42:43		15 min
Pure - P						2.16			0.07	0	1			Apr 26		15 min
Chi-X - X						2.28	+0.12	5.6	0.4	1	4	2.23 2.28 2.23		09:42:43		15 min
CX2 - H						2.27	+0.11	5.1	0.5	1	1	2.27 2.27 2.27		09:32:17		15 min
CXD - D						2.21	+0.05	2.3	1.9	4	2	2.21 2.21 2.21		09:31:33		15 min
TriAct - M						2.16			0.2	0	2			Sep 04/20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 64

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
09:42:54	P	2.23	0.07	65	7 TD Sec	19 Desjardins	E
09:42:54	V	2.24	0.08	900	79 CIBC	19 Desjardins	K
09:42:43	U	2.29	0.13	200	85 Scotia	39 Merrill Lynch	K
09:42:43	X	2.28	0.12	100	85 Scotia	79 CIBC	K
09:42:43	V	2.28	0.12	100	85 Scotia	79 CIBC	K
09:42:43	V	2.28	0.12	100	85 Scotia	79 CIBC	K
09:42:43	V	2.29	0.13	600	85 Scotia	1 Anonymous	K
09:42:43	V	2.27	0.11	100	85 Scotia	79 CIBC	K
09:42:43	V	2.28	0.12	500	85 Scotia	1 Anonymous	K
09:42:43	V	2.28	0.12	1,000	85 Scotia	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-05-02 07:54	C:NGEN	2.16	In the News525	Globe says new coverage rates Nervgen Pharma "buy"
2024-04-25 12:29	C:NGEN	2.09	News Release200	Nervgen Pharma hires Russo Partners for PR
2024-04-18 00:17	C:NGEN	1.98	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-04-18 00:17	C:NGEN	1.98	SEDAR MD & A815	SEDAR MD & A
2024-04-17 14:20	C:NGEN	2.02	News Release200	Nervgen Pharma's Dec. 31 cash at $11.7-million
2024-04-03 20:43	C:NGEN	2.34	Prospectus Approved3	Nervgen Pharma prospectus offering
2024-03-28 13:21	C:NGEN	2.18	News Release200	Nervgen Pharma closes $23.01-million bought deal
2024-03-22 07:38	C:NGEN	2.49	Resume Trading385	Nervgen Pharma resuming at the open
2024-03-21 16:12	C:NGEN	2.49	News Release200	Nervgen Pharma arranges $20-million offering
2024-03-21 15:51	C:NGEN	2.55	Halt Trading170	Nervgen Pharma halted at 12:43 p.m. PT
2024-02-20 17:47	C:NGEN	3.32	News Release200	Nervgen grants options to buy shares
2024-02-15 13:06	C:NGEN	3.01	News Release200	Nervgen to complete NVG-291 enrolment in Q2 2024
2023-11-09 14:25	C:NGEN	1.96	News Release200	Nervgen Pharma's Sept. 30 cash at $14.8-million
2023-11-09 10:12	C:NGEN	1.96	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-11-09 10:12	C:NGEN	1.96	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-10-23 11:30	C:NGEN	1.79	News Release200	Nervgen receives fast-track designation for NVG-291
2023-10-17 13:01	C:NGEN	1.75	News Release200	Nervgen appoints Ruffolo as director
2023-09-25 09:56	C:NGEN	2.05	News Release200	Nervgen doses first patient in spinal cord injury trial
2023-08-09 15:25	C:NGEN	1.85	News Release200	Nervgen cash and investments at $16.1M at June 30
2023-08-09 08:28	C:NGEN	1.85	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements